Chemo Drug Effective For Kids With Sickle Cell Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 21, 2025.

By Dennis Thompson HealthDay Reporter

MONDAY, April 21, 2025 -- An oral chemotherapy drug can safely and effectively manage sickle cell disease in children, a new study says.

Children taking hydroxyurea had fewer ER visits and spent fewer days in the hospital compared to kids not taking the drug, researchers reported April 17 in the journal Blood Advances.

“Our results reinforce that hydroxyurea, the most efficacious medicine available for sickle cell disease, continues to have really important benefits over time for pediatric patients,” lead researcher Dr. Paul George, a pediatric hematology/oncology fellow at Emory University School of Medicine in Atlanta, said in a news release.

Sickle cell disease (SCD) is the most common inherited red blood cell disorder in the U.S., affecting an estimated 100,000 people, researchers said in background notes. One in every 365 Black children and one in every 16,300 Hispanic children are born with the disease.

The disorder causes abnormally shaped red blood cells that are sickle-shaped and sticky. If they become lodged in a person’s veins, they can block blood flow and cause organ damage, infection and episodes of severe pain.

Hydroxyurea is taken once a day, and has been shown to reduce the frequency and severity of SCD pain crises, researchers said. The drug also decreases the need for blood transfusions, improves anemia, and reduces the risk of clots blocking blood vessels in the lungs.

The drug helps red blood cells stay round and flexible, rather than sickle-shaped, according to St. Jude Children’s Research Hospital.

Federal regulators currently recommend that hydroxyurea be offered to patients with severe sickle cell disease starting between 9 and 12 months of age, researchers noted.

“Hydroxyurea has been a mainstay in sickle cell disease treatment for a long time, but was initially used as a chemotherapy, so there have always been some lingering fears about its safety and efficacy, especially for children,” researcher Dr. Wilbur Lam, a professor of pediatrics and biomedical engineering at Emory University, said in a news release.

“This study can reassure patients and their families that this therapy, one of the most accessible for SCD, continues to be a safe option with a true benefit outside of a controlled setting,” Lam added.

For the study, researchers tracked 2,147 children under age 18 with sickle cell disease treated at least three times between 2010 and 2021 at the Children’s Hospital of Atlanta.

Of the children, 58% had used hydroxyurea. The average time on hydroxyurea was about five years, with 304 kids age 8 or older on continuous therapy with the drug.

Kids taking hydroxyurea consistently had fewer ER visits and days in the hospital, even after researchers accounted for the severity of their sickle cell disease and adherence to the drug therapy.

“Overall, hydroxyurea remained effective over time in these children,” George said. “However, one important takeaway from this study is that improvements in hemoglobin concentration – or reductions in anemia – were seen only in patients whose data indicated they were regularly taking the medication.”

Sources

  • Emory University, news release, April 17, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-04-22 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords